Bob D Brown Dicerna Pharmaceuticals Inc (DRNA) insider trading activity

Bob D Brown is Chief Scientific Ofr., EVP R&D of Dicerna Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of DRNA, which is worth approximately $0. The most recent transaction as insider was on Mar 01, 2021, when has been sold 8,312 shares (Common Stock) at a price of $9.09 per share, resulting in proceeds of $75,556. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Bob D Brown Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2021	BUY Exercise of conversion of derivative security	$75,556 $9.09 p/Share	8,312 Added 21.79%	29,829 Common Stock
Feb 03 2021	SELL Open market or private sale	$207,800 $25.0 p/Share	8,312 Reduced 27.87%	21,517 Common Stock
Feb 03 2021	BUY Exercise of conversion of derivative security	$75,556 $9.09 p/Share	8,312 Added 21.79%	29,829 Common Stock
Jan 25 2021	SELL Open market or private sale	$540,750 $25.0 p/Share	21,630 Reduced 50.13%	21,517 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$151,167 $9.09 p/Share	16,630 Added 27.82%	43,147 Common Stock
Jan 12 2021	SELL Open market or private sale	$139,799 $24.07 p/Share	5,808 Reduced 17.97%	26,517 Common Stock
Jan 08 2021	SELL Payment of exercise price or tax liability	$66,190 $23.29 p/Share	2,842 Reduced 8.08%	32,325 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	-	8,650 Added 19.74%	35,167 Common Stock
Dec 01 2020	SELL Open market or private sale	$206,180 $25.19 p/Share	8,185 Reduced 23.59%	26,517 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$27,993 $3.42 p/Share	8,185 Added 19.09%	34,702 Common Stock
Nov 02 2020	SELL Open market or private sale	$172,131 $21.03 p/Share	8,185 Reduced 23.59%	26,517 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$27,993 $3.42 p/Share	8,185 Added 19.09%	34,702 Common Stock
Oct 16 2020	SELL Open market or private sale	$343,770 $21.0 p/Share	16,370 Reduced 38.17%	26,517 Common Stock
Oct 16 2020	BUY Exercise of conversion of derivative security	$55,985 $3.42 p/Share	16,370 Added 27.63%	42,887 Common Stock

BDB

Bob D Brown

Chief Scientific Ofr., EVP R&D

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Dicerna Pharmaceuticals Inc insider buys or sells DRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dicerna Pharmaceuticals Inc

Track Activities on DRNA

Account